Abcellera provides covid-19 program update with the start of phase 3 clinical trials and the expansion of its covid-19 antibody database

Abcellera today announced that ly-cov555, a potential treatment and prophylaxis for covid-19, has progressed to phase 3 clinical trials.

EKSO Ratings Summary

EKSO Quant Ranking